Aquestive Therapeutics Stock Quote AQST - Stock Price, News, Charts, Message Board, Trades

Professional-Grade Tools, for Individual Investors.

Premium

Current Price

3.04

Bid

2.95

Ask

3.26

Volume

0.00 Day's Range 0.00

1.2514 52 Week Range 6.23

Market Cap

276.757M

Previous Close

3.04

Open

Last Trade

Last Trade Time

Financial Volume

VWAP

Average Volume (3m)

1,707,450

Shares Outstanding

91,038,532

Dividend Yield

PE Ratio

-35.19

Earnings Per Share (EPS)

-0.09

Revenue

50.58M

Net Profit

-7.87M

Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier stage pipeline for the t... Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Sympazan Oral Film, Suboxone Sublingual Film, Exservan Oral Film, and Zuplenz. The product pipeline includes Libervant Buccal Film, AQST-108, and AQST-305. The majority of its revenue comes from the United States. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.aquestive.com

Headquarters

Wilmington, Delaware, USA

Founded

1970

Aquestive Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker AQST. The last closing price for Aquestive Therapeutics was $3.04. Over the last year, Aquestive Therapeutics shares have traded in a share price range of $ 1.2514 to $ 6.23.

Aquestive Therapeutics currently has 91,038,532 shares outstanding. The market capitalization of Aquestive Therapeutics is $276.76 million. Aquestive Therapeutics has a price to earnings ratio (PE ratio) of -35.19.

Aquestive Therapeutics to Participate in Leerink Partners Therapeutics Forum: I&I and Metabolism

WARREN, N.J., June 27, 2024 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ: AQST) (“Aquestive” or the “Company”), a pharmaceutical company advancing medicines to bring meaningful...

Aquestive Therapeutics Reports Positive Topline Data from Temperature / pH Study of Anaphylm™ (epinephrine) Sublingual Film

Anaphylm pharmacokinetic results unaffected by oral cavity exposure to liquids of different temperatures and pHRemains on track to complete Anaphylm supportive clinical studies and expects to...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0.56	22.5806451613	2.48	3.1	2.405	1396193	2.76026452	CS
4	0.4	15.1515151515	2.64	3.1	2.24	2074306	2.56793672	CS
12	-1.21	-28.4705882353	4.25	4.2799	2.24	1707450	3.00862469	CS
26	0.43	16.4750957854	2.61	6.23	2.24	2046855	3.74647057	CS
52	1.48	94.8717948718	1.56	6.23	1.2514	1214656	3.46253573	CS
156	-0.4	-11.6279069767	3.44	6.4	0.618	767255	2.92630127	CS
260	-1.25	-29.1375291375	4.29	10	0.618	761683	3.93619911	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
SHIMShimmick Corporation	$ 3.29 (58.94%)	334.67k
APVOAptevo Therapeutics Inc	$ 0.4439 (32.51%)	1.53M
ASSTAsset Entities Inc	$ 1.78 (13.38%)	4.7k
BIRDAllbirds Inc	$ 0.7768 (12.89%)	1
GTLBGitLab Inc	$ 57.00 (12.51%)	11.71k
FIVEFive Below Inc	$ 89.49 (-12.32%)	4.45k
SILOSilo Pharma Inc	$ 2.15 (-10.04%)	70.93k
DATSDatChat Inc	$ 1.69 (-9.14%)	732
NAASNaaS Technology Inc	$ 4.25 (-8.80%)	7.43k
MIRAMIRA Pharmaceuticals Inc	$ 0.7401 (-8.63%)	1
APVOAptevo Therapeutics Inc	$ 0.4439 (32.51%)	1.53M
SHIMShimmick Corporation	$ 3.29 (58.94%)	334.67k
MAXNMaxeon Solar Technologies Ltd	$ 0.237 (-6.10%)	268.84k
NVDANVIDIA Corporation	$ 123.80 (-2.03%)	259.82k
SQQQProShares UltraPro Short QQQ	$ 7.705 (3.28%)	253.07k